ABSTRACT
INTRODUCTION

Traumatic brain injury (TBI) is recognized as one of the most common causes of death in
persons under age 45, with a large societal impact in terms of resource utilization and health care costs, while the human suffering is incalculable. Each year in the United States, there are over 2 million cases, 220,000 hospitalizations, and 52,000 deaths from head trauma; while another 80-90,000 persons each year suffer permanent debilitation.
The total cost of TBI in the United States, both direct healthcare and indirect personal and societal costs, is estimated at $44 billion per annum . While the causal mechanisms of TBI cross a spectrum from low height falls to sports related head impacts to blunt high speed motor vehicle injuries, the underlying pathophysiology remains similar. Autopsy studies from patients with injury classifications ranging from concussion to severe traumatic brain injury often demonstrate diffuse injury to white matter tracts running from the cortex to the brainstem.
The extent of traumatic axonal injury (TAI) is a principal determinant of morbidity and mortality following traumatic brain injury.
While various studies have given hope that pharmacological or physiological interventions may reduce axonal injury, to date over 30 major clinical studies have failed to show a significant effect in reducing the morbidity and mortality or improving This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. revised 6/2/2010 outcomes of TBI (Doppenberg EM et al., 1997) . Advances in treatment strategies in the clinical management of the acute injury, critical care and rehabilitation medicine starting have greatly improved both the survival and functional outcomes. The science of nutritional supplementation has undergone significant change from early goals of simply delivering necessary calories to current regimens which provide specific amino acid and fatty acid combinations to maximize the healing process. Docosahexaenoic acid (DHA), the principle constituent O3FA of neural tissue, demonstrates significant antiinflammatory properties and is the precursor of Neuroprotectin 1. Recent evidence from animal studies suggests that supplementation with O3FA (particularly eicosapentaenoic acid (EPA) and DHA) improves functional outcomes following focal neural injury ( This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. revised 6/2/2010
METHODS
Marmarou impact acceleration injury model in rats
Four groups of ten (n=40) of adult male Sprague-Dawley rats were subjected to a Marmarou impact acceleration injury resulting in reproducible traumatic brain injury.
Rats weighing between 350 and 400 grams received isoflurane induction anesthesia and subsequently maintained on inhaled isoflurane using a modified medical anesthesia machine. Lidocaine 1% local anesthetic was injected subcutaneously along the planned incision site. Buprenorphine was used for postoperative analgesia. Body temperature was controlled during the approximately 10 minute procedure using a heating blanket, and adequate sedation was confirmed by evaluation of response to heel tendon pinch. The animals were shaved and prepared in sterile fashion for surgery, followed by subcutaneous injection of local anesthetic into the planned incision site. A 3cm midline incision in the scalp was made, periosteal membranes separated, exposing bregma and lambda. A metal disk 10mm in diameter and 3mm thick was attached to the skull with cyanoacrylate and centered between bregma and lambda. The animal is placed prone on a foam bed with the metal disk directly under a plexiglas tube. A 450-gram brass weight is dropped a single time through the tube from a height of 2 meters striking the disk. The animal is then ventilated on 100% O 2 while the skull is inspected, the disk removed, and the incision repaired. When the animal recovers spontaneous respirations, anesthesia is discontinued and the animal is returned to its cage for postoperative observation (Marmarou et al., 1994) . All procedures involving live animals were approved by the Institutional Animal Care and Use Committee of West Virginia University, and are performed according to the principles of the Guide for the Care and Use of Laboratory from 50 microliter blood samples using a previously described method (Holub and Skeaff, 1987 ) (Nutrasource Diagnostics, University of Guelph, Ontario, Canada). This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. revised 6/2/2010 paraformaldehyde for 24 hours. Following 24 hours fixation, the brain was blocked by cutting the brainstem above the pons, cutting the cerebellar peduncles, and then making sagittal cuts lateral to the pyramids. The resulting tissue containing the corticospinal tracts and the medial lemnisci, areas shown previously to yield traumatically injured axons, was then sagitally cut on a vibratome into 50 micron thick sections. The tissue underwent temperature controlled microwave antigen retrieval using previously described techniques (Stone JR et al., 1999) . The tissue was preincubated in a solution containing 10% normal serum and 0.2% Triton X in PBS for 40 minutes. The slides were sealed with acrylic and stored in the dark in a laboratory refrigerator (Mills et al., 2003) ).
Tissue Preparation and Immunhistochemical Labeling
Fluorescent Microscopy and Image analysis
The tissue was examined and images acquired using a laser scanning confocal microscope system (Zeiss) with an Argon 488 excitation laser and a 40x objective lens.
Ten digital images are obtained from the tissue of each animal and images were then This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. revised 6/2/2010 randomized. Individual injured axons were independently counted and data was stored in a spreadsheet (Microsoft Corp.). Counts were converted to density per mm2 by the formula axon count per image / image area. Differences between group means were determined using paired t-tests and considered significant if the probability value was less than 0.05. were marked. The volume of the ROI was determined using the Cavalieri method, the volume of the sum of the counting frames was calculated, the sum total of injured axons within the counting frames was calculated, and an estimate of the number of APP positive axons per cubic mm was calculated. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. revised 6/2/2010
Stereological Quantification of axonal injury
RESULTS
Impact Acceleration Model and Serum Fatty Acid Levels
The mortality rate in this model of traumatic axonal injury was 0%. Animals tolerated daily oral supplementation without any observed untoward effects.
Supplementation for 30 days after the brain trauma with DHA at dosage of either 10mg/kg/day or 40mg/kg/day resulted in increased levels of serum DHA of 123 and 176% over initial levels, respectively (Figure 1.). Animals receiving no supplementation had a 7% decrease in DHA. Serum EPA levels likewise increased in supplemented animals 104 and 313%, respectively; while unsupplemented animals showed a 59%
decrease. The AA:EPA ratio, a marker of inflammation, decreased 72 and 109%, respectively, while increasing 65% in unsupplemented animals.
Immunohistochemical analysis of APP positive axons
In This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. Likewise, a significant decrease in active caspase-3 positive axons provides additional evidence for the neuroprotective and injury ameliorating effects of DHA.
Serum response
Analysis of the serum phospholipids at the end of the supplementation period after the traumatic insult showed a dose-response effect by an increase in the total of both EPA and DHA levels as compared to the sham animals, whereas there was a decrease in the combined EPA and DHA serum levels in the non-supplemented animals. These results are consistent with previous studies in both rats and humans which demonstrate uptake and retroconversion of DHA into EPA (Vidgren et al, 1997, Brossard et al, 1996).
Interestingly, there was an increase in the serum arachidonic acid levels in the nonsupplementated group although non-significant increase was seen in the supplemented animals. As a result, the AA/EPA ratio, an indicator of systemic inflammation, significantly increased in the non-supplemented animals compared to the supplemented animals. This would have the effect of activating leukocytes into neutrophils and macrophages that could more easily enter into the brain. Dosage with 10mg/kg/day or 40mg/kg/day reflect typical human equivalent DHA supplemental dosing with between 1 and 3 grams per day. 
Omega-3 Fatty Acids
The primary O3FA's are EPA and DHA. Prior work from our lab with the same head injury model has shown that dietary supplementation with a fish oil concentrate rich in This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
